YMAB

Y mAbs Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 43.06 04:52:25
Open Price Low Price High Price Close Price Prev Close
43.06
more quote information »

Recent News

Date Time Source Heading
1/21/202116:17EDGARStatement of Changes in Beneficial Ownership (4)
1/20/202116:17EDGARStatement of Changes in Beneficial Ownership (4)
1/07/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202109:00GLOBEY-mAbs Therapeutics to Present At 39th Annual J.P. Morgan..
12/28/202009:00GLOBEY-mAbs Announces Sale of Priority Review Voucher
12/22/202017:16EDGARCurrent Report Filing (8-k)
12/18/202010:39EDGARCurrent Report Filing (8-k)
12/18/202009:05GLOBEY-mAbs Signs License Agreement with SciClone for DANYELZA®..
12/18/202009:00GLOBEY-mAbs Signs Distribution Agreement with Swixx for DANYELZA®..
12/17/202016:39EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:07EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:06EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:06EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:05EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:05EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:04EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:04EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202018:04EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202009:00GLOBEY-mAbs Announces Pipeline Update
12/14/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
12/09/202016:16EDGARCurrent Report Filing (8-k)
12/09/202009:00GLOBEY-mAbs Announces Update on DANYELZA® (naxitamab-gqgk) at..
12/07/202009:00GLOBEY-mAbs to Host Virtual Research & Development Day on..
12/04/202018:01EDGARStatement of Changes in Beneficial Ownership (4)
12/04/202009:09EDGARCurrent Report Filing (8-k)
12/04/202009:00GLOBEY-mAbs and Takeda Announce Exclusive License and..
12/02/202016:16EDGARStatement of Changes in Beneficial Ownership (4)
11/25/202017:30EDGARCurrent Report Filing (8-k)
11/25/202017:02GLOBEFDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the..
11/20/202016:16EDGARStatement of Changes in Beneficial Ownership (4)
11/19/202010:33EDGARCurrent Report Filing (8-k)
11/19/202009:00GLOBEY-mAbs Announces Update on Omburtamab in DIPG
11/17/202016:16EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202017:51EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202016:43EDGARQuarterly Report (10-q)
11/05/202016:38EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202016:09EDGARCurrent Report Filing (8-k)
11/05/202016:01GLOBEY-mAbs Announces Third Quarter 2020 Financial Results and..
10/29/202009:00GLOBEY-mAbs to Announce Third Quarter 2020 Financial and..
10/26/202009:48EDGARCurrent Report Filing (8-k)
10/26/202009:10GLOBEY-mAbs Announces FDA Clearance of IND for Lutetium-177..
10/19/202016:16EDGARStatement of Changes in Beneficial Ownership (4)
10/16/202009:00GLOBEY-mAbs Announces Update on Naxitamab and Omburtamab in..
10/14/202009:07EDGARCurrent Report Filing (8-k)
10/14/202009:00GLOBEY-mAbs Announces FDA Clearance of IND for its Lutetium-177..
10/08/202016:31EDGARCurrent Report Filing (8-k)
10/07/202009:19EDGARCurrent Report Filing (8-k)
10/07/202009:00GLOBEY-mAbs’ Nivatrotamab for the Treatment of Patients with..
10/06/202007:52EDGARCurrent Report Filing (8-k)
10/05/202016:01GLOBEY-mAbs Provides Regulatory Update on Omburtamab for the..
See more news about this stock »
Your Recent History
NASDAQ
YMAB
Y mAbs The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210128 10:12:32